|
🐜
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
49 auth.
J. Smolen,
R. Landewé,
J. Bijlsma,
G. Burmester,
K. Chatzidionysiou,
M. Dougados,
J. Nam,
S. Ramiro,
M. Voshaar,
R. V. van Vollenhoven,
D. Aletaha,
M. Aringer,
M. Boers,
C. Buckley,
F. Buttgereit,
...
V. Bykerk,
M. Cardiel,
B. Combe,
M. Cutolo,
Y. van Eijk-Hustings,
P. Emery,
A. Finckh,
C. Gabay,
J. Gómez-Reino,
L. Gossec,
J. Gottenberg,
J. Hazes,
T. Huizinga,
M. Jani,
D. Karateev,
M. Kouloumas,
T. Kvien,
Zhanguo Li,
X. Mariette,
I. McInnes,
E. Mysler,
P. Nash,
K. Pavelka,
G. Poór,
C. Richez,
P. V. van Riel,
A. Rubbert-Roth,
K. Saag,
J. D. da Silva,
T. Stamm,
T. Takeuchi,
R. Westhovens,
M. D. de Wit,
D. M. van der Heijde
|
11 |
2010 |
11
🐜
|
|
🐜
|
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
43 auth.
J. Smolen,
F. Breedveld,
G. Burmester,
V. Bykerk,
M. Dougados,
P. Emery,
T. Kvien,
M. V. Navarro-Compán,
S. Oliver,
M. Schoels,
M. Scholte-Voshaar,
T. Stamm,
M. Stoffer,
T. Takeuchi,
D. Aletaha,
...
J. Andreu,
M. Aringer,
Martin Bergman,
N. Betteridge,
H. Bijlsma,
H. Burkhardt,
M. Cardiel,
B. Combe,
P. Durez,
J. Fonseca,
A. Gibofsky,
J. Gómez-Reino,
W. Graninger,
P. Hannonen,
B. Haraoui,
M. Kouloumas,
R. Landewé,
E. Martı́n-Mola,
P. Nash,
M. Ostergaard,
A. Östör,
P. Richards,
T. Sokka-Isler,
C. Thorne,
A. Tzioufas,
R. V. van Vollenhoven,
M. D. de Wit,
D. M. van der Heijde
|
10 |
2015 |
10
🐜
|
|
🐜
|
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
7 auth.
D. Aletaha,
V. Nell,
T. Stamm,
M. Uffmann,
S. Pflugbeil,
K. Machold,
...
J. Smolen
|
9 |
2005 |
9
🐜
|
|
🐜
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
48 auth.
J. Smolen,
R. Landewé,
S. Bergstra,
A. Kerschbaumer,
A. Sepriano,
D. Aletaha,
R. Caporali,
C. Edwards,
K. Hyrich,
J. Pope,
Savia de Souza,
T. Stamm,
T. Takeuchi,
P. Verschueren,
K. Winthrop,
...
A. Balsa,
J. Bathon,
M. Buch,
G. Burmester,
F. Buttgereit,
M. Cardiel,
K. Chatzidionysiou,
C. Codreanu,
M. Cutolo,
A. D. den Broeder,
K. El Aoufy,
A. Finckh,
J. Fonseca,
J. Gottenberg,
E. Haavardsholm,
A. Iagnocco,
K. Lauper,
Zhanguo Li,
I. McInnes,
E. Mysler,
P. Nash,
G. Poór,
G. Ristić,
F. Rivellese,
A. Rubbert-Roth,
H. Schulze-Koops,
N. Stoilov,
Anja Strangfeld,
A. H. M. van der Helm-van Mil,
E. van Duuren,
T. V. Vliet Vlieland,
R. Westhovens,
D. M. van der Heijde
|
9 |
2022 |
9
🐜
|
|
🐜
|
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
37 auth.
J. Smolen,
Monika Schöls,
J. Braun,
M. Dougados,
O. FitzGerald,
D. Gladman,
A. Kavanaugh,
R. Landewé,
P. Mease,
J. Sieper,
T. Stamm,
M. D. de Wit,
D. Aletaha,
X. Baraliakos,
N. Betteridge,
...
F. E. Van den Bosch,
L. Coates,
P. Emery,
L. Gensler,
L. Gossec,
P. Helliwell,
Merryn Jongkees,
T. Kvien,
R. Inman,
I. McInnes,
M. Maccarone,
P. Machado,
A. Moltó,
A. Ogdie,
D. Poddubnyy,
C. Ritchlin,
M. Rudwaleit,
A. Tanew,
B. Thio,
D. Veale,
K. de Vlam,
D. M. van der Heijde
|
9 |
2017 |
9
🐜
|
|
🐬
|
Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states.
D. Aletaha,
M. Ward,
K. Machold,
V. Nell,
T. Stamm,
J. Smolen
|
9 |
2005 |
9
🐬
|
|
🐜
|
Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis
8 auth.
V. Nell,
K. Machold,
T. Stamm,
G. Eberl,
H. Heinzl,
M. Uffmann,
...
J. Smolen,
G. Steiner
|
8 |
2005 |
8
🐜
|
|
🐜
|
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative
26 auth.
L. Gossec,
M. D. de Wit,
U. Kiltz,
J. Braun,
U. Kalyoncu,
R. Scrivo,
M. Maccarone,
L. Carton,
K. Otsa,
Imre Sooäär,
T. Heiberg,
H. Bertheussen,
J. Cañete,
A. Sánchez Lombarte,
A. Balanescu,
...
Alina Dinte,
K. de Vlam,
J. Smolen,
T. Stamm,
D. Niedermayer,
G. Békés,
D. Veale,
P. Helliwell,
Andrew Parkinson,
T. Luger,
T. Kvien
|
8 |
2014 |
8
🐜
|
|
🐢
|
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update
18 auth.
M. Stoffer,
M. Schoels,
J. Smolen,
D. Aletaha,
F. Breedveld,
G. Burmester,
V. Bykerk,
M. Dougados,
P. Emery,
B. Haraoui,
...
J. Gómez-Reino,
T. Kvien,
P. Nash,
V. Navarro-Compán,
M. Scholte-Voshaar,
R. V. van Vollenhoven,
D. M. van der Heijde,
T. Stamm
|
8 |
2015 |
8
🐢
|
|
🐜
|
Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.
8 auth.
K. Machold,
T. Stamm,
V. Nell,
S. Pflugbeil,
D. Aletaha,
G. Steiner,
...
M. Uffmann,
J. Smolen
|
8 |
2006 |
8
🐜
|
|
🐬
|
Individual interviews and focus groups in patients with rheumatoid arthritis: a comparison of two qualitative methods
M. Coenen,
T. Stamm,
G. Stucki,
A. Cieza
|
7 |
2011 |
7
🐬
|
|
🐜
|
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2
19 auth.
R. Landewé,
P. Machado,
F. Kroon,
H. Bijlsma,
G. Burmester,
L. Carmona,
B. Combe,
Massimo Galli,
L. Gossec,
A. Iagnocco,
...
J. Isaacs,
X. Mariette,
I. McInnes,
U. Mueller-Ladner,
P. Openshaw,
J. Smolen,
T. Stamm,
D. Wiek,
H. Schulze-Koops
|
7 |
2020 |
7
🐜
|
|
🐜
|
Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease.
7 auth.
K. Machold,
T. Stamm,
G. Eberl,
V. Nell,
A. Dunky,
M. Uffmann,
...
J. Smolen
|
7 |
2002 |
7
🐜
|
